Industry Trends

Loading...

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More



Investigative Sites: The Trouble with e-Clinical Technologies



Loading...

By Deb Borfitz

June 1, 2009 | Even the most progressive, tech-savvy investigative sites are aggravated by many of the e-clinical systems being embraced by study sponsors. Virtually no type of clinical trial technology escapes criticism, but EDC systems seem to be the biggest offenders, according to several sites that spoke to eCliniqua about their experience.

Surprisingly, technical problems loom large. Today’s EDC systems typically have the horsepower to process large volumes of data simultaneously, but still manage to create more rather than less work and expense than they did in 1995, says Kelly Walker, director of operations at Research Across America (RAA), an independent site network based in Dallas.

The biggest problem is with web-based EDC systems that get placed on servers and networks “not nearly robust enough to handle the workload,” says Walker. In some cases, web pages won’t “refresh” correctly because the browser is trying to cache those pages to reduce server load and perceived lag. Although there are cache-control settings to rectify the problem, site personnel aren’t instructed how to make the necessary adjustments.

Another ongoing issue is the variability with which EDC systems support different versions of foundational software such as Internet Explorer and Adobe Reader, says Walker. “It means study coordinators working on two different studies [often] need two different computers on their desk.” Site staff can also inadvertently wreak havoc whenever they respond to automated promptings to update any of that underlying software.

That sponsors now have the ability to instantaneously reformat pages or add new questions to electronic case report forms (CRFs) has also created problems for RAA, says Walker. Sites are expected to gather the new information retroactively on patients who probably don’t remember if that headache they had several months earlier was mild, moderate, or severe. Other times there is rampant indecision about what should count as an adverse event, leaving sites to alternatively delete and re-insert data. The high turnover rate among study monitors is a contributing factor, he adds.

Perhaps the biggest technical oddity at RAA is that two of the three PCs outfitting Walker’s office won’t display CRF pages correctly. Date field boxes are missing and no manner of technical support can figure out why. “Our people have had to learn how to enter data without the boxes….where they know [from experience] the answers should go.”

Pedia Queries

Richard_Litov
Richard Litov
At Pedia Research, the chief complaint about EDC systems is that they often generate unnecessary queries, says Richard Litov, director of the dedicated, three-site network based in Owensboro, KY. To avoid answering umpteen of these automatically generated queries, site personnel wait until they have every last piece of patient visit information (including lab results) before entering any data at all. Often contributing to the query problem is that the software fails to help users at the sites visualize what information is missing or incomplete without the time-consuming process of opening each individual screen.

CRF pages written in-house by large companies using the Oracle database are the bane of Diane Palmer, site administrator and clinical research coordinator at Coastal Connecticut Research (CCR), a dedicated site in New London. With one recent study, the site had to enter data on 46 separate pages for every neurological exam done by the investigator. Each exam took only ten minutes, but data entry took a whopping 90 minutes. “We almost quit recruiting for the study because we were losing money.”

Part of the problem is that headers are frequently not pre-populated with data from their previous visit, says Palmer, meaning someone at the site has to constantly re-key the visit date in the prescribed format—i.e. 03 May 2009 versus May 3, 2009 or, if the date is unknown, “not done” versus “ND” or “00.” To make matters worse, each CRF page often contains only one or two data fields that have to be filled in and saved before moving on to the next set of questions.

Palm Pilot-type based electronic patient diaries also aren’t particularly popular with the interviewed sites. One recent e-diary study at Pedia Research was a “complete disaster,” says Litov. Patients ended up making entries on paper and the site struggled to re-key the information into the unwilling system. In this case, the central problem was a rushed timeline. “The poor vendor didn’t have enough time to get the system ready to go, error-free.”

Patient misuse of the technology is part of the problem, says Walker, but the bigger issue is that e-dairies don’t mimic clinical practice. If study participants fail to take a pill at the exact time specified—something patients in the real world pretty much never do—the data they enter will be rejected. Questions can also be oddly or unclearly posed, confusing patients. Diaries appear at times to erroneously record entries about symptoms, disqualifying subjects who seem perfectly suited to a study.

The vendors, of course, blame the site or the user. But Walker says such predicaments happen often enough that the technology must be called into question.

 

Click here to log in.

1 Comments

  • avatar

    What a great article, i was just about to write a similar article for my blog on the problem. The other dilemma that is hinted at in the article but not stated outright. Investigators are paid for the time infront of the patient and not for completing forms or data entry. The reality is that data entry/editing/cleaning is now over sixty percent of the workload of most studies and the sites are not being reimbursed . The question is what would be a reasonable model to bill for that kind of work, as we are now billing on a per visit basis.

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.